`___________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________
`
`LANNETT HOLDINGS, INC.,
`Petitioner,
`
`v.
`
`ASTRAZENECA AB,
`Patent Owner.
`____________________________________________
`
`Case: IPR2015-01629
`
`U.S. Patent No. 6,750,237
`____________________________________________
`
`
`
`PATENT OWNER’S EXHIBIT LIST
`(as of December 28, 2015)
`
`
`
`
`
`
`
`Case No. IPR2015-01629
`U.S. Patent No. 6,750,237
`
`
`
`
`Exhibits
`Description
`Exhibit 2001 Complaint, Impax Laboratories, Inc. v. Lannett Holdings, Inc.,
`C.A. No. 1:14-cv-00984-RGA, D.I. 1 (D. Del. July 25, 2014).
`
`Exhibit 2002
`
`Summons in a Civil Action, Impax Laboratories, Inc. v.
`Lannett Holdings, Inc., C.A. No. 1:14-cv-00984-RGA, D.I. 5
`(D. Del. July 29, 2014).
`
`Exhibit 2003 D. Del. LR 4.1.
`
`Exhibit 2004 Del. Code Ann. tit. 8, § 132.
`Exhibit 2005 Complaint, Impax Laboratories, Inc. v. Lannett Holdings, Inc.,
`C.A. No. 1:14-cv-00999-RGA, D.I. 1 (D. Del. July 30, 2014).
`Exhibit 2006 Answer, Impax Laboratories, Inc. v. Lannett Holdings, Inc.,
`C.A. No. 1:14-cv-00999-RGA, D.I. 11 (D. Del. Sept. 24, 2014).
`
`Exhibit 2007
`
`Motion to Dismiss, Impax Laboratories, Inc. v. Lannett
`Holdings, Inc., C.A. No. 1:14-cv-00984-RGA, D.I. 9 (D. Del.
`Sept. 24, 2014).
`
`Exhibit 2008
`
`Memorandum in Support of Motion to Dismiss, Impax
`Laboratories, Inc. v. Lannett Holdings, Inc., C.A. No. 1:14-cv-
`00984-RGA, D.I. 10 (D. Del. Sept. 24, 2014).
`
`Exhibit 2009
`
`Assignment of Assignor’s Interest, Reel/Frame 12996-425
`(2002), microformed on Assignment Search (U.S. Patent and
`Trademark Office).
`
`Exhibit 2010 Assignment of Application No. 10/129,773.
`
`Exhibit 2011
`
`Memorandum Order, Impax Laboratories, Inc. v. Lannett
`Holdings, Inc., C.A. No. 1:14-cv-00984-RGA, D.I. 33 (D. Del.
`Dec. 10, 2014).
`
`Exhibit 2012 PHYSICIAN’S DESK REFERENCE (55th ed. 2001).
`
`
`
`1
`
`
`
`Case No. IPR2015-01629
`U.S. Patent No. 6,750,237
`
`
`Exhibit 2013 Registry Listing for CAS Registry Number 139264-17-8, STN
`(retrieved Sept. 9, 2015).
`Exhibit 2014 USP DICTIONARY OF USAN AND INTERNATIONAL DRUG NAMES
`1998 (Jean Ross Canada ed., 1997).
`Exhibit 2015 Charles Q. Meng, Migraine: Current Drug Discovery Trend, 4
`CURRENT MED. CHEMISTRY 385 (1997).
`Exhibit 2016 Registry Listing for CAS Registry Number 139264-17-8,
`SCIFINDER (retrieved Sept. 14, 2015).
`Exhibit 2017 OXFORD DICTIONARY OF BIOCHEMISTRY AND MOLECULAR
`BIOLOGY (A.D. Smith et al. eds., 1997).
`
`Exhibit 2018
`
`GlaxoSmithKline LLC v. Banner Pharmacaps, Inc., No. 11-cv-
`00046, 2013 U.S. Dist. LEXIS 112440 (D. Del. August 9,
`2013).
`
`Exhibit 2019 N.V. BHAGAVAN, MEDICAL BIOCHEMISTRY (1992).
`Exhibit 2020 HAWLEY’S CONDENSED CHEMICAL DICTIONARY (Richard J.
`Lewis, Sr. ed., 12th ed. 1993).
`Exhibit 2021 DICTIONARY OF BIOTECHNOLOGY (James Coombs ed., Stockton
`Press 2d ed. 1992).
`Exhibit 2022 THE UNITED STATES PHARMACOPEIA AND THE NATIONAL
`FORMULARY (24th ed. 2000).
`
`Exhibit 2023
`
`INT’L PHARM. EXCIPIENTS COUNCIL, QUALIFICATIONS OF
`EXCIPIENTS FOR USE IN PHARMACEUTICALS (2008).
`Exhibit 2024 Sterility Requirement for Aqueous-Based Drug Products for
`Oral Inhalation, 65 Fed. Reg. 34,082 (May 26, 2000).
`Exhibit 2025 App. No. 10/854,959, Decl. Under 37 C.F.R. § 1.132 of Dr. Ed
`Cahill, Nov. 11, 2005.
`
`
`
`2
`
`
`
`
`Exhibit 2026 WILLIAM L. MASTERTON ET AL., CHEMICAL PRINCIPLES (John J.
`Vondeling et al. ed., 5th ed. 1981).
`
`Case No. IPR2015-01629
`U.S. Patent No. 6,750,237
`
`Exhibit 2027
`
`Entity Details for Lannett Holdings, Inc., DELAWARE DIVISION
`OF CORPORATIONS (Dec. 20, 2015),
`https://icis.corp.delaware.gov/Ecorp/EntitySearch/NameSearch.
`aspx.
`
`Exhibit 2028 Del. Code Ann. tit. 8, § 321.
`
`Exhibit 2029
`
`In re Hechinger Inv. Co. of Delaware, Inc., 287 B.R. 620
`(Bankr. D. Del. 2002).
`Exhibit 2030 Keith v. Melvin L. Joseph Constr. Co., 451 A.2d 842 (Del.
`Super. Ct. 1982).
`
`Exhibit 2031
`
`Delaware Registered Agent, CORPORATION SERVICE COMPANY
`(Dec. 11, 2015),
`https://www.cscglobal.com/service/cls/delaware-registered-
`agent.
`
`Exhibit 2032
`
`Civil Docket for Impax Laboratories, Inc. v. Lannett Holdings,
`Inc., C.A. No. 1:14-cv-00984-RGA, PACER (retrieved Dec. 21,
`2015).
`
`Exhibit 2033
`
`Stipulation for Extension of Time, Impax Laboratories, Inc. v.
`Lannett Holdings, Inc., C.A. No. 1:14-cv-00984-RGA, D.I. 7
`(D. Del. Aug. 14, 2014).
`Exhibit 2034 Pfizer Inc. v. Teva Pharm. USA, Inc., 803 F. Supp. 2d 409
`(E.D. Va. 2011).
`
`
`
`3
`
`
`
`Case No. IPR2015-01629
`U.S. Patent No. 6,750,237
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`By: /Maureen D. Queler /
`Michael J. Flibbert, Reg. No. 33,234
`Maureen D. Queler, Reg. No. 61,879
`Finnegan, Henderson, Farabow, Garrett
`& Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`(202) 408-4000
`
`Counsel for Patent Owner
`
`
`
`
`
`
`
`Dated: December 28, 2015
`
`
`
`4
`
`
`
`Case No. IPR20l5-01629
`
`Patent 6,750,237
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing PATENT
`
`OWNER’S EXHIBIT LIST and Exhibits 2027-2034 was served electronically
`
`Via e—mail on December 28, 2015, in its entirety on the following:
`
`Joseph F. Posillico
`Fox Rothschild LLP
`
`2000 Market Street, 20th Floor
`
`Philadelphia, PA 19103
`ipdocket@foxrothschild.corn
`jposillico@foxrothschild.com
`
`Frank T. Carroll
`
`Fox Rothschild LLP
`
`2000 Market Street, 20th Floor
`
`Philadelphia, PA 19103
`ipdocket@foxrothschild.com
`fcarroll@foXrothschild.com
`
`Petitioner has agreed to electronic service.
`
`Dated: December 28, 2015
`
`FINNEGAN, HE
`
`ERSON, FARABOW,
`
`GARRETT & DUNNER, LLP